advertisment

Your new biomedical search engine
try: asthma , trastuzumab , BRCA1 , Collins, F 		Advanced Search
Preferences
Search in:
Show highlight panel
Sign Up for mynovoseek and enjoy more functionalities in novoseek sign up for free now!
About novoseek

Free biomedical search engine that allows you to find literature in Pubmed, Free Full Text and U.S. Grants. Explore the results in an easy way, narrow and identify relevant results quickly.

Check tutorial video
Read a use case

Key concepts


Click here for more info about 'DHCR7'
DHCR7
ranking
Click here for more info about 'smith-lemli-opitz sy...'
smith-lemli-opitz sy...
ranking
Click here for more info about 'cholesterol synthesi...'
cholesterol synthesi...
ranking
Click here for more info about 'vitamin d3'
vitamin d3
ranking
Click here for more info about 'STEROL'
STEROL
ranking
more
Print

Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.

Am J Med Genet A 2010,Aug,01;152A(8):2094-8; (PMID: 20635399)
Publication Type: Journal Article, Research Support, N.I.H., Intramural
American journal of medical genetics. Part A
Section on Molecular Dysmorphology, Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, DHHS, Bethesda, MD, USA.
article abstract
Smith-Lemli-Opitz syndrome (SLOS) is a malformation syndrome resulting from mutations of the 7-dehydrocholesterol reductase (DHCR7) gene. During cholesterol biosynthesis, DHCR7 catalyzes the conversion of 7-dehydrocholesterol (7DHC) to cholesterol. A clinical diagnosis of SLOS is confirmed biochemically by the presence of elevated levels of 7DHC. Phenotypic severity of SLOS has previously been shown to correlate with the 7DHC/cholesterol ratio. We describe a patient with a severe SLOS phenotype, but a very low serum 7DHC/cholesterol ratio. We show that this discordance is due to alternative splicing of a previously unreported IVS5+3 A>T mutation. This mutation results in the transcription of both normal and mutant mRNA transcripts. We postulate that alternative splicing of the IVS5+3 A>T results in insufficient DHCR7 activity during embryogenesis, but sufficient DHCR7 activity once cholesterol synthetic rates decrease postnatally. This unique case underscores the adjunctive use of fibroblast and molecular testing in ambiguous cases of SLOS and may provide insight into the potential efficacy of therapeutic interventions altering postnatal cholesterol biosynthesis.
Your search has been saved.
Your search contains date ranges. It can be saved but no alerts can be created. To create an alert please repeat the search without date ranges.
myns_savedsearch.alertcreated
close
Your search has been saved.
Do you want to create an email alert?
close

Labels will enable you to:

  • Organize your favorite papers.
  • Classify interesting documents.
  • Retrieve your labeled documents from anywhere at anytime.

To assign your labels to the documents we need you to sign-in or create an account.

close

Saving search results will enable you to:

  • Retrieve saved results from anywhere at anytime.
  • Set up emails alerts on your favorite searches.

To keep all this information stored we need you to sign-in or create an account.

close

novoseek allows you to:

  • Claim authorship of your work.
  • Specify the different aliases you have in your work.
  • Build your profile and your author page!

To keep all this information stored we need you to sign-in or create an account.

The entity has already been added to the filters
This article will be available in PMC on .
Create Label close
Name of label: